We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LBPH market cap is 790.94M. The company's latest EPS is USD -1.5110 and P/E is -14.53.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -11.88M | -11.73M | -11.96M | -15.64M | -13.58M |
Net Income | -11.6M | -11.35M | -11.46M | -15M | -12.93M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -14.4M | -27.84M | -44.8M | -56.76M |
Net Income | -14.4M | -27.8M | -43.95M | -54.42M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 80.66M | 70.62M | 79.68M | 66.22M | 58.86M |
Total Liabilities | 8.62M | 9.15M | 7.55M | 8.12M | 6.82M |
Total Equity | 72.04M | 61.47M | 72.13M | 58.11M | 52.04M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 56.24M | 108.95M | 70.62M | 50.7M |
Total Liabilities | 3.14M | 5.63M | 9.15M | 9.77M |
Total Equity | -2.69M | 103.32M | 61.47M | 40.92M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -28.39M | -38.06M | -13.1M | -26.55M | -39.84M |
Investing | -19.21M | -17.06M | 6.08M | 14.05M | 25.79M |
Financing | N/A | -444k | 21.36M | 21.24M | 27.18M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -3.44M | -24.71M | -38.06M | -50.87M |
Investing | N/A | -40.72M | -17.06M | 24.23M |
Financing | 58.76M | 76.45M | -444k | 30.19M |
Market Cap | 790.94M |
Price to Earnings Ratio | -14.53 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 55.16 |
Price to Book Ratio | 19.32 |
Dividend Yield | - |
Shares Outstanding | 36.02M |
Average Volume (1 week) | 302.25k |
Average Volume (1 Month) | 387.9k |
52 Week Change | 163.31% |
52 Week High | 28.15 |
52 Week Low | 3.60 |
Spread (Intraday) | 2.84 (12.26%) |
Company Name | Longboard Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.longboardpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions